NASDAQ:MLTX | Income Statement | MoonLake Immunotherapeutics

Complete source-backed income-statement history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$50.22M$61.66M-$61.66M$90,000.00-$61.81M-$0.84-$0.8473,915,29673,915,296
2026-03-31$54.52M$70.02M-$70.02M$622,000.00-$69.71M-$0.98-$0.9871,273,65071,273,650
2025-12-31$56.01M$65.22M-$65.22M$248,000.00-$62.43M-$0.92-$0.921,167,8901,167,890
2025-09-30$60.64M$71.43M-$71.43M$115,000.00-$69.73M-$1.10-$1.1063,369,98463,369,984
2025-06-30$49.76M$60.7M-$60.7M$95,000.00-$55.22M-$0.87-$0.8763,282,72863,282,728
2025-03-31$36.46M$47.49M-$47.49M$153,000.00-$39.94M-$0.63-$0.6363,233,78863,233,788
2024-12-31$40.36M$49.58M-$49.58M$41,000.00-$45.61M-$0.72-$0.7267,01767,017
2024-09-30$35.74M$43.11M-$43.11M$92,000.00-$35.39M-$0.56-$0.5662,896,78262,896,782
2024-06-30$23.66M$30.58M-$30.58M$79,000.00-$24.27M-$0.39-$0.3962,874,63762,874,637
2024-03-31$13.01M$19.82M-$19.82M$70,000.00-$13.67M-$0.22-$0.2262,637,21262,637,212
2023-12-31$8.1M$15.03M-$15.03M$43,920.00-$7.44M-$0.10-$0.103,636,8843,636,884
2023-09-30$7.59M$12.98M-$12.98M$28,923.00-$9.43M-$0.18-$0.1853,517,65553,517,655
2023-06-30$8.7M$13.19M-$13.19M$10,149.00-$10.14M-$0.23-$0.2343,718,46443,718,464
2023-03-31$7.42M$12.93M-$12.93M$11,010.00-$9M-$0.23-$0.2339,061,97739,061,977
2022-12-31$11.37M$16.7M-$16.7M$11,012.00-$17.11M-$0.43-$0.433,530,7933,530,793
2022-09-30$9.02M$14.77M-$14.77M$8,740.00-$10.11M-$0.27-$0.2736,925,63936,925,639
2022-06-30$11.4M$17.65M-$17.65M$9,282.00-$12.12M-$0.34-$0.3435,201,71335,201,713
2022-03-31$10.45M$15.94M-$15.94M$7,774.00$7,332.00-$15.88M-$3.17-$3.175,013,6465,013,646
2021-12-31$34.73M$2,255.00$34.78M350,310,373
2021-09-30$669,528.00$6.27M-$6.27M$1,481.00$0.00-$6.29M-$2.63-$2.632,390,5872,390,587
2021-06-30$29.87M$32.68M-$32.68M$6,140.00$0.00-$32.69M-$2.90-$2.9011,278,99111,278,991
2021-03-31-$94,106.00$17,815.00-$76,291.00

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$202.86M$244.83M-$244.83M-$229.71M$611,000.00-$227.32M-$3.53-$3.5364,463,88964,463,889
2024-12-31$112.77M$143.09M-$143.09M-$120.96M$282,000.00-$118.94M-$1.89-$1.8962,870,23762,870,237
2023-12-31$31.8M$54.12M-$54.12M-$43.99M$94,000.00-$36.01M-$0.73-$0.7349,122,53449,122,534
2022-12-31$42.05M$65.06M-$65.06M-$64.47M$36,366.00-$49.97M-$1.70-$1.7029,361,35329,361,353
2021-12-31-$4.57M$27,691.00-$4.54M360,000,000